Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12012435 FimH mutant, compositions therewith and use thereof

Patent 12012435 was granted and assigned to Janssen Pharmaceuticals on June, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Janssen Pharmaceuticals
Janssen Pharmaceuticals
0
Date Filed
July 26, 2022
0
Date of Patent
June 18, 2024
0
Patent Applicant
Janssen Pharmaceuticals
Janssen Pharmaceuticals
0
Patent Application Number
17814966
0
Patent Citations
‌
US Patent 9149522 Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
0
‌
US Patent 9415097 Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
0
‌
US Patent 9415101 Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
0
‌
US Patent 9504743 Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
0
‌
US Patent 9700612 Polysaccharide and uses thereof
0
‌
US Patent 10441647 Polysaccharide and uses thereof
0
‌
US Patent 10456462 Vaccine against RSV
0
‌
US Patent 11421003 FimH mutant, compositions therewith and use thereof
0
‌
US Patent 11229694 Vaccine against RSV
0
‌
US Patent 7357936 Adjuvant systems and vaccines
0
•••
Patent Inventor Names
Jeroen Geurtsen
0
Marleen Eveline Weerdenburg
0
Cristhina Kellen Fae
0
Jakob Louris Feitsma
0
Jan Grijpstra
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12012435
0
Patent Primary Examiner
‌
S. Devi
0

Find more entities like US Patent 12012435 FimH mutant, compositions therewith and use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo